- Home
- BCPC
BCPC
Balchem Corporation
as 08-06-2025 12:31pm EST
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
| Founded: | 1967 | Country: | United States |
| Employees: | N/A | City: | MONTVALE |
| Market Cap: | 5.2B | IPO Year: | N/A |
| Target Price: | $189.00 | AVG Volume (30 days): | 186.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Annual | |
| EPS: | 4.36 | EPS Growth: | 21.42 |
| 52 Week Low/High: | $145.70 - $185.96 | Next Earning Date: | 07-31-2025 |
| Revenue: | $985,930,000 | Revenue Growth: | 5.74% |
| Revenue Growth (this year): | 8.74% | Revenue Growth (next year): | 6.85% |
Latest Balchem Corporation News
BCPC Breaking Stock News: Dive into BCPC Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Balchem Corporation to Present at the CJS Annual New Ideas Summer Conference on July 10, 2025
Argus Research
2 months ago
BCPC: Raising target price to $176.00
GlobeNewswire
2 months ago
Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025
GlobeNewswire
3 months ago
Balchem Corporation to Participate in the dbAccess Global Consumer Conference on June 4, 2025
Argus Research
3 months ago
BCPC: Raising target price to $179.00
Argus Research
3 months ago
BCPC: Raising target price to $173.00
Simply Wall St.
3 months ago
Should You Investigate Balchem Corporation (NASDAQ:BCPC) At US$165?
Argus Research
3 months ago
BCPC: Raising target price to $172.00
Compare BCPC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BCPC Balchem Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.